This month’s Special Report offered 2 overviews of current approaches to treating migraine headache – in children/adolescents and in women with menstrual migraine—and a preview of a new generation monoclonal antibodies created to prevent migraine, the calcitonin gene-related peptide (CGRP) inhibitors. The authors, all directors of headache clinics, covered topics including:
• Migraine prophylaxis in pediatric patients
• Appropriate use and dosing of OTC analgesics in adolescents
• How to differentiate menstrual migraine from perimenstrual headaches
• Risks and benefits associated with current preventive treatments for migraine
• The science of and promise in the CGRP inhibitor class of preventive migraine drugs
The pretest linked to the Special Report introduction offered a chance to see what you already knew about the treatment of this challenging neurologic disease.
Click on the link below for the post-test which presents the same questions so you can gauge how much you have learned. Links to all sections of the Special Report are offered at the end of the posttest. Good luck!